Sites & offices

Our worldwide supply chain and manufacturing infrastructure meets the highest standards of quality and performance. We fully comply with GMP and environmental, health and safety (EHS) standards and consistently exceed internal and external customer service expectations.

Synthon leverages its vertically integrated business model over various locations. We have globally-oriented API or drug product manufacturing facilities in the Czech Republic, Argentina, Spain and Chile. Our subsidiary in Chile is also active in the direct commercialization of a diverse portfolio of products to the local market, as is our affiliate in Mexico.

State-of-the-art facilities

With our state-of-the-art biopharmaceutical laboratories and GMP facilities for the manufacture of monoclonal antibodies (mAbs) and the production of antibody-drug conjugates (ADCs) - up to Phase III clinical trials and early launches - in our main campus in the Netherlands, our worldwide infrastructure is fully rigged up, positioning us to deliver on our ambitions. Furthermore, Synthon has dedicated business development offices in the United States, Russia and South Korea. We intend to continue expanding globally and are continually seeking new partners for our products in all major markets.

Environment, health and safety

Synthon monitors the wellbeing of our employees and the EHS priority areas. We do our utmost to ensure that all our employees and contractors can return home safely and in good health. 

read more

     Share this page